Hledání v detailu akcií
Moje portfolio
Nastavit Oblíbené, nastavit Portfolio
Oblíbené tituly
select
NázevNejlepší
nákup
Nejlepší
prodej
Změna
(%)
ČEZ0,00
KB0,00
PKN63,7263,8-0,13
Msft0,76
Nokia3,924-0,38
IBM0,98
Daimler AG36,6136,63-1,35
PFE2,28
03.07.2020 18:04:05
Indexy online
AD Index online
select
AD Index online
 

  • 03.07.2020 2:04:04
ResMed (RMD, NY Consolidated)
Poslední obchod Změna (%) Změna (USD) Objem obchodů (ks)
192,48 0,85 1,62 623 139
R - Real-Time data si mohou aktivovat klienti Patria Plus / Investor Plus ZDE.

 
  • Poslední aktualizace: 05.07.2020
Popis společnosti
Obecné informace
Název společnostiResMed Inc.
TickerRMD
Kmenové akcie:Ordinary Shares
RICRMD
ISINUS7611521078
Prioritní akciePreference Shares
Poslední známé roční výsledky30.06.2019
Poslední známé čtvrtletní výsledky31.03.2020
Počet zaměstnanců k 30.06.2019 7 240
Akcie v oběhu k 27.04.2020 144 668 429
Počet akcionářů k 30.06.2019 20
MěnaUSD
Konstituent indexůS&P 500
Kontaktní informace
Ulice9001 Spectrum Center Blvd
MěstoSAN DIEGO
PSČ92123-1438
ZeměUnited States
Kontatní osoba 
Funkce kontaktní osoby 
Telefon18 587 462 400
Fax13026365454

Business Summary: ResMed Inc. is a holding company. The Company is engaged in the development, manufacturing, distribution and marketing of medical devices and cloud-based software applications that diagnose, treat and manage respiratory disorders, including sleep disordered breathing (SDB), chronic obstructive pulmonary disease (COPD), neuromuscular disease and other diseases. The Company operates through two segments: Sleep and Respiratory Care segment, and the Software-as-a-Service (SaaS) segment. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. Its cloud-based software digital health applications, along with its devices, are designed to provide connected care to improve patient outcomes. The Company's portfolio of products includes devices, diagnostic products, mask systems, headgear and other accessories, dental devices, portable oxygen concentrators (POCs) and cloud-based software informatics solutions.
Financial Summary: BRIEF: For the nine months ended 31 March 2020, ResMed Inc. revenues increased 15% to $2.19B. Net income before extraordinary items increased 32% to $443.8M. Revenues reflect an increase in demand for the Company's products and services due to favorable market conditions. Net income benefited from Acquisition-related expenses decrease from $6.1M (expense) to $0K, Litigation settlement expenses increase from $0K to $600K (income).
Odvětvová klasifikace
TRBC2009Advanced Medical Equipment
TRBC2012Advanced Medical Equipment & Technology - NEC
RBSS2004Advanced Medical Equipment
MGINDUSTRYMedical Equipment & Supplies
MGSECTORHealthcare
NAICSElectromedical and Electrotherapeutic Apparatus Manufacturing
NAICSSurgical and Medical Instrument Manufacturing
NAICSSurgical Appliance and Supplies Manufacturing
NAICSOffices of Other Holding Companies
SICSurgical And Medical Instruments
SICElectromedical Equipment
SICSurgical And Medical Instruments
SICSurgical Appliances And Supplies
SICHolding Companies, Nec



  • Poslední aktualizace: 05.07.2020
Management společnosti
FunkceJménoVěkVe funkci odVe firmě od
President, Chief Operating OfficerRobert Douglas6001.03.2013
Chief Executive Officer, DirectorMichael Farrell4701.03.2013
Chief Financial OfficerBrett Sandercock5201.01.2006
President – Sleep BusinessJim Hollingshead5601.03.2013
President – Respiratory Care BusinessRichard McHale55
President – Software as a Service Business (SaaS)Raj Sodhi46
Chief Administrative Officer, Global General Counsel, SecretaryDavid Pendarvis6023.05.2011